Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Partnering at AMAL Therapeutics
Partnering at Boehringer Ingelheim
A very happy holiday season from the whole AMAL team, and a great start into 2021!
AMAL Therapeutics SA announces the appointment of Dr. Thomas Bogenrieder as Chief Clinical Officer
We are very happy to welcome Thomas Bogenrieder, MD, PhD, as Chief Clinical Officer of AMAL Therapeutics as of July 1, 2020. Thomas will join AMAL’s operations in Geneva.
Page 1 of 1
Filter news by year